Products Categories
| CAS No.: | 2030-63-9 |
|---|---|
| Name: | Clofazimine |
| Molecular Structure: | |
|
|
|
| Formula: | C27H22Cl2N4 |
| Molecular Weight: | 473.404 |
| Synonyms: | Phenazine,3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-(6CI,7CI,8CI);2-(4-Chloroanilino)-3-isopropylimino-5-(4-chlorophenyl)-3,5-dihydrophenazine;2-p-Chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine;3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine;B 663 (pharmaceutical);Clofazimine;G 30320;Hansepran;Lampren;Lamprene;NSC 141046; |
| EINECS: | 217-980-2 |
| Density: | 1.29 g/cm3 |
| Melting Point: | 210-212° |
| Boiling Point: | 566.9 °C at 760 mmHg |
| Flash Point: | 296.7 °C |
| Solubility: | 10mg/L(temperature not stated) |
| Hazard Symbols: |
 Xn,  Xi
|
| Risk Codes: | 22-36/37/38 |
| Safety: | 36-26 |
| PSA: | 42.21000 |
| LogP: | 7.61120 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 211914-50-0N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
- 240444-70-62,3,5,6-Tetrafluor-4-(methoxymethyl)benzyl-2,2-dimethyl-3-(prop-1-en-1-yl)cyclopropancarboxylat
- 84803-71-4
1,5-bis-(4-chloro-phenyl)-2,2-dimethyl-2,5-dihydro-1H-imidazo[4,5-b]phenazine
- 2030-63-9
clofazimine
| Conditions | Yield |
|---|---|
| With ethanol; platinum Hydrogenation; |
- 75-31-0
isopropylamine
- 102262-55-5
N,5-bis(4-chlorophenyl)-3-imino-3,5-dihydrophenazin-2-amine
- 2030-63-9
clofazimine
| Conditions | Yield |
|---|---|
| In 1,4-dioxane Reflux; | 61 g |
- 2030-63-9
clofazimine
- 106690-93-1
4-bromo-3-(2-bromo-4-chloroanilino)-10-(4-chlorophenyl)-2,10-dihydro-2-isopropylminophenazine
| Conditions | Yield |
|---|---|
| With bromine In tetrachloromethane; chloroform for 8h; | 78% |
- 2030-63-9
clofazimine
- 115603-94-6
5-(4-chloro-phenyl)-2-(2,N-dibromo-4-chloro-anilino)-3-isopropylamino-phenazinium betaine
| Conditions | Yield |
|---|---|
| With chloroform; bromine |
- 2030-63-9
clofazimine
- 106691-12-7
{1-Chloro-5-(4-chloro-phenyl)-3-[(Z)-isopropylimino]-3,5-dihydro-phenazin-2-yl}-(2,4-dichloro-phenyl)-amine
| Conditions | Yield |
|---|---|
| With sulfuryl dichloride |
| Conditions | Yield |
|---|---|
| With sodium acetate; hydrogen chloride In water-d2 pH=2; |
- 2030-63-9
clofazimine
| Conditions | Yield |
|---|---|
| With ammonium chloride In methanol; water |
What can I do for you?
Get Best Price
Specification
The Clofazimine, with CAS registry number 2030-63-9, has the systematic name of (3Z)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine. And its IUPAC name is N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine. What's more, its EINECS is 217-980-2.
Physical properties of Clofazimine: (1)ACD/LogP: 7.26; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 5.3; (4)ACD/LogD (pH 7.4): 6.11; (5)ACD/BCF (pH 5.5): 2111.2; (6)ACD/BCF (pH 7.4): 13667.52; (7)ACD/KOC (pH 5.5): 2303.57; (8)ACD/KOC (pH 7.4): 14912.88; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 39.99 Å2; (13)Index of Refraction: 1.666; (14)Molar Refractivity: 136.18 cm3; (15)Molar Volume: 366 cm3; (16)Polarizability: 53.98×10-24cm3; (17)Surface Tension: 47 dyne/cm; (18)Enthalpy of Vaporization: 85.11 kJ/mol; (19)Vapour Pressure: 7.19E-13 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
The Clofazimine irritates to eyes, respiratory system and skin. When use it, wear suitable protective clothing, gloves and eye/face protection. If contact with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
(1)SMILES: CC(C)\N=C/2\C=C/3\N(c4ccccc4\N=C\3\C=C\2\Nc1ccc(Cl)cc1)c5ccc(Cl)cc5
(2)InChI: InChI=1/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24-
(3)InChIKey: WDQPAMHFFCXSNU-KRUMMXJUBA
(4)Std. InChI: InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24-
(5)Std. InChIKey: WDQPAMHFFCXSNU-KRUMMXJUSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| guinea pig | LD50 | oral | 4400mg/kg (4400mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 794, 1970. | |
| mouse | LD50 | oral | > 5gm/kg (5000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 794, 1970. | |
| rabbit | LD50 | oral | 1500mg/kg (1500mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 794, 1970. | |
| rat | LD50 | oral | 8400mg/kg (8400mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 794, 1970. |